APOE and Alzheimer disease: While this varies, most studies suggest that APOE4 effects on AD risk are greater in women and some suggest an age‐by‐sex specific interaction where APOE4 heterozygote women have an increased risk at younger ages.14, 19, 36, 37, 38, 39